Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000411902 | SCV000488904 | likely benign | Multiple endocrine neoplasia, type 1 | 2016-07-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000411902 | SCV000554168 | benign | Multiple endocrine neoplasia, type 1 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001706621 | SCV001844823 | likely benign | not provided | 2019-02-27 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256225 | SCV002530078 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-29 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV000411902 | SCV004018050 | benign | Multiple endocrine neoplasia, type 1 | 2024-09-05 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
Center for Genomic Medicine, |
RCV003321585 | SCV004027122 | uncertain significance | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing |